Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
Part of paid clinical trials in Augusta, Georgia.
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Study ID
- NCT04301765
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cancer
- Fatigue
- Hypogonadism, Male
Eligibility Criteria
- Sex
- MALE
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- testosterone 1.62% gel — DRUGThe gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months
- placebo gel — OTHERThe gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months
Study Details
This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Key Dates
- Start date
- Jan 12, 2021
- Status verified
- Mar 2026
- Primary completion
- Nov 1, 2026
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 230 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: testosterone 1.62% gelTestosterone 1.62% gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months.
- Placebo Comparator: placebo gelThe placebo gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months.
Primary Outcome Measure
Fatigue change [ Time Frame: 6 months ]
Central Contacts
- Jose Garcia, MD, Phd206 764 2984
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | Egidio Del Fabbro, MD |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Shehzad Basaria, MD (PRINCIPAL_INVESTIGATOR) |
| Veterans Affairs Puget Sound Health Care System | Seattle | Washington | 98108 | Jose M Garcia, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Augusta, GA
Related Studies
- Evaluation of Non-Invasive Assays for the Detection of Urothelial CancerRecruiting · Lahey Clinic · Burlington, Massachusetts
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6PHASE2 · Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts